×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [21]
山东大学 [7]
上海药物研究所 [5]
中国医学科学院 北京... [5]
自动化研究所 [4]
清华大学 [1]
更多...
内容类型
会议论文 [51]
发表日期
2019 [1]
2018 [3]
2017 [13]
2016 [3]
2015 [4]
2014 [3]
更多...
学科主题
gastroente... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共51条,第1-10条
帮助
限定条件
内容类型:会议论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Correlation of radiomic features with epidermal growth factor receptor mutation stat us in advanced lung adenocarcinoma..
会议论文
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), JUN 22-25, 2019
作者:
Sun, Xiaorong
;
Xing, Ligang
;
Wang, Changbin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/31
Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors
会议论文
作者:
Zhang, Ao
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/01/08
Clinicopathologic characteristics and genomic essence analyses revealed estrogen receptor positive, progesterone receptor negative and human epidermal growth factor receptor 2 negative breast cancer to be more basal-like and endocrine resistant
会议论文
作者:
Liu, Xiyu
;
Ma, Ding
;
Jiang, Yi-Zhou
;
Liu, Yi-Rong
;
Yu, Ke-Da
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Stage I lung adenocarcinoma appearing as a ground-glass nodule: relationship between 18F-FDG PET/CT parameters with high-resolution CT findings and epidermal growth factor receptor mutation
会议论文
作者:
Zhou, Jun
;
Mao, Wujian
;
Zhang, He
;
Shi, Hongcheng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer
会议论文
作者:
Lu, Shun
;
Chang, Jianhua
;
Liu, Xiaoqing
;
Shi, Jianhua
;
Lu, You
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
PROGRESSION FREE SURVIVAL
vascular endothelial growth factor receptor
third-line treatment
Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib
会议论文
作者:
Liu, Fatao
;
Zhou, Yi
;
Zhou, Zhen
;
Liu, Yun
;
Chen, Zhiwei
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
lung adenocarcinoma
methyl-sensitive cut counting sequencing (MSCC)
methylation
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation.
会议论文
作者:
Xing, Ligang
;
Wu, Gang
;
Wang, Lvhua
;
Li, Jian-Cheng
;
Wang, Jianhua
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer
会议论文
作者:
Lu, Shun
;
Chang, Jianhua
;
Liu, Xiaoqing
;
Shi, Jianhua
;
Lu, You
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
PROGRESSION FREE SURVIVAL
vascular endothelial growth factor receptor
third-line treatment
The Main Treatment Failure Pattern for Completely Resected Stage II-IIIA (N1-N2) EGFR-Mutation Positive Lung Cancer
会议论文
作者:
Xu, S.
;
Zhong, W.
;
Zhang, Y.
;
Mao, W.
;
Wu, L.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
non-small-cell lung cancer (NSCLC)
epidermal growth factor receptor (EGFR) mutation
High Probability and Frequency of EGFR Mutations in Non-Small Cell Lung Cancer with Brain Metastases
会议论文
作者:
Ge, M.
;
Zhan, Q.
;
Huang, R.
;
Zhou, X.
;
Liang, X.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
Epidermal growth factor receptor
brain metastases
©版权所有 ©2017 CSpace - Powered by
CSpace